使HIV-1疫苗的研发之路更加清晰。 - Suppr

Bringing the path toward an HIV-1 vaccine into focus.

作者信息

Lopez Angel Cesar J, Tomaras Georgia D

机构信息

Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, United States of America.

Duke Center for Human Systems Immunology, Duke University School of Medicine, Durham, North Carolina, United States of America.

出版信息

PLoS Pathog. 2020 Sep 10;16(9):e1008663. doi: 10.1371/journal.ppat.1008663. eCollection 2020 Sep.

DOI:10.1371/journal.ppat.1008663

PMID:32913360

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7482965/

Abstract

摘要

相似文献

Bringing the path toward an HIV-1 vaccine into focus.使HIV-1疫苗的研发之路更加清晰。

PLoS Pathog. 2020 Sep 10;16(9):e1008663. doi: 10.1371/journal.ppat.1008663. eCollection 2020 Sep.

HIV Vaccines: One Step Closer.HIV 疫苗：更近一步。

Trends Mol Med. 2017 Jan;23(1):1-3. doi: 10.1016/j.molmed.2016.10.006. Epub 2016 Nov 23.

HIV/AIDS Vaccines: 2018.艾滋病疫苗：2018 年。

Clin Pharmacol Ther. 2018 Dec;104(6):1062-1073. doi: 10.1002/cpt.1208. Epub 2018 Oct 9.

HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine development.HIV-1包膜糖蛋白gp41广泛中和抗体：疫苗开发的障碍

PLoS Pathog. 2014 May 22;10(5):e1004073. doi: 10.1371/journal.ppat.1004073. eCollection 2014 May.

HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure.基于抗体鉴定、B 细胞发生和表位结构的 HIV-1 疫苗。

Immunity. 2018 May 15;48(5):855-871. doi: 10.1016/j.immuni.2018.04.029.

Germinal Center Lymphocyte Ratios and Successful HIV Vaccines.生发中心淋巴细胞比值与有效的 HIV 疫苗。

Trends Mol Med. 2017 Feb;23(2):95-97. doi: 10.1016/j.molmed.2016.12.009. Epub 2017 Jan 12.

Genetic and immune correlates of the HIV infection and vaccine-induced immunity. Foreword.HIV感染与疫苗诱导免疫的遗传和免疫关联。前言。

Vaccine. 2008 Jun 6;26(24):2949-50. doi: 10.1016/j.vaccine.2008.02.003. Epub 2008 Feb 13.

HIV vaccine development--improving on natural immunity.HIV疫苗研发——改进天然免疫

N Engl J Med. 2011 Sep 8;365(10):873-5. doi: 10.1056/NEJMp1107621.

HIV/AIDS: allied responses.艾滋病毒/艾滋病：联合应对措施

Nature. 2007 Sep 6;449(7158):29-30. doi: 10.1038/449029a.

HIV vaccine: hopes and hurdles.HIV 疫苗：希望与挑战。

Drug Discov Today. 2011 Nov;16(21-22):948-56. doi: 10.1016/j.drudis.2011.08.013. Epub 2011 Aug 26.

引用本文的文献

GeM-LR: Discovering predictive biomarkers for small datasets in vaccine studies.GeM-LR：在疫苗研究中发现小数据集的预测生物标志物。

PLoS Comput Biol. 2024 Nov 14;20(11):e1012581. doi: 10.1371/journal.pcbi.1012581. eCollection 2024 Nov.

Immunoinformatic Identification of Multiple Epitopes of gp120 Protein of HIV-1 to Enhance the Immune Response against HIV-1 Infection.免疫信息学鉴定 HIV-1 gp120 蛋白的多个表位以增强针对 HIV-1 感染的免疫应答。

Int J Mol Sci. 2024 Feb 19;25(4):2432. doi: 10.3390/ijms25042432.

Statistical and machine learning methods for immunoprofiling based on single-cell data.基于单细胞数据的免疫分析的统计和机器学习方法。

Hum Vaccin Immunother. 2023 Aug 1;19(2):2234792. doi: 10.1080/21645515.2023.2234792. Epub 2023 Jul 24.

Evolution of Multiple Domains of the HIV-1 Envelope Glycoprotein during Coreceptor Switch with CCR5 Antagonist Therapy.HIV-1 包膜糖蛋白在与 CCR5 拮抗剂治疗共受体转换过程中多个结构域的进化。

Microbiol Spectr. 2022 Aug 31;10(4):e0072522. doi: 10.1128/spectrum.00725-22. Epub 2022 Jun 21.

Higher mucosal antibody concentrations in women with genital tract inflammation.生殖道炎症女性的黏膜抗体浓度更高。

Sci Rep. 2021 Dec 6;11(1):23514. doi: 10.1038/s41598-021-02954-0.

Fighting HIV-1 Persistence: At the Crossroads of "Shoc-K and B-Lock".对抗HIV-1潜伏：处于“休克与封锁”的十字路口

Pathogens. 2021 Nov 20;10(11):1517. doi: 10.3390/pathogens10111517.

Preventive HIV Vaccines-Leveraging on Lessons from the Past to Pave the Way Forward.预防性HIV疫苗——借鉴过往经验，铺就前行道路。

Vaccines (Basel). 2021 Sep 8;9(9):1001. doi: 10.3390/vaccines9091001.

Mutation Rates, Mutation Frequencies, and Proofreading-Repair Activities in RNA Virus Genetics.RNA 病毒遗传学中的突变率、突变频率和校对修复活性。

Viruses. 2021 Sep 21;13(9):1882. doi: 10.3390/v13091882.

In silico design and in vitro expression of novel multiepitope DNA constructs based on HIV-1 proteins and Hsp70 T-cell epitopes.基于 HIV-1 蛋白和 Hsp70 T 细胞表位的新型多表位 DNA 构建体的计算机设计和体外表达。

Biotechnol Lett. 2021 Aug;43(8):1513-1550. doi: 10.1007/s10529-021-03143-9. Epub 2021 May 13.

HIV-1 Entry and Prospects for Protecting against Infection.HIV-1病毒的进入机制及预防感染的前景

Microorganisms. 2021 Jan 22;9(2):228. doi: 10.3390/microorganisms9020228.

本文引用的文献

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.南非 HVTN 100 中健康 HIV 阴性成人 12 个月加强免疫后的安全性和免疫应答：ALVAC-HIV（vCP2438）和二价 C 亚型 gp120/MF59 疫苗的随机双盲安慰剂对照试验。

PLoS Med. 2020 Feb 24;17(2):e1003038. doi: 10.1371/journal.pmed.1003038. eCollection 2020 Feb.

HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens.HIV-1 疫苗序列影响 V1V2 抗体反应：两种痘病毒初免 gp120 加强疫苗方案的比较。

Sci Rep. 2020 Feb 7;10(1):2093. doi: 10.1038/s41598-020-57491-z.

Targeted selection of HIV-specific antibody mutations by engineering B cell maturation.通过工程化 B 细胞成熟来靶向选择 HIV 特异性抗体突变。

Science. 2019 Dec 6;366(6470). doi: 10.1126/science.aay7199.

The complex challenges of HIV vaccine development require renewed and expanded global commitment.艾滋病病毒疫苗研发面临的复杂挑战需要全球做出新的、更广泛的承诺。

Lancet. 2020 Feb 1;395(10221):384-388. doi: 10.1016/S0140-6736(19)32682-0. Epub 2019 Dec 2.

Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk.抗体 Fc 效应功能和 IgG3 与降低 HIV-1 风险相关。

J Clin Invest. 2019 Nov 1;129(11):4838-4849. doi: 10.1172/JCI126391.

Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial.Fc 受体多态性调节 HVTN 505 艾滋病毒疫苗试验中 HIV-1 风险的疫苗效果。

J Virol. 2019 Oct 15;93(21). doi: 10.1128/JVI.02041-18. Print 2019 Nov 1.

A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge.一种减毒活 RhCMV/SIV 疫苗对异源 SIV 攻击显示出长期疗效。

Sci Transl Med. 2019 Jul 17;11(501). doi: 10.1126/scitranslmed.aaw2607.

Mind the Gap: How Interspecies Variability in IgG and Its Receptors May Complicate Comparisons of Human and Non-human Primate Effector Function.注意差距：IgG 及其受体在种间的差异如何使人类和非人类灵长类动物效应功能的比较复杂化。

Front Immunol. 2019 Apr 8;10:697. doi: 10.3389/fimmu.2019.00697. eCollection 2019.

Advancing an HIV vaccine; advancing vaccinology.推进艾滋病疫苗研究；推进疫苗学发展。

Nat Rev Immunol. 2019 Feb;19(2):77-78. doi: 10.1038/s41577-018-0103-6.

Tracing HIV-1 strains that imprint broadly neutralizing antibody responses.追踪广泛中和抗体反应所印记的 HIV-1 株。

Nature. 2018 Sep;561(7723):406-410. doi: 10.1038/s41586-018-0517-0. Epub 2018 Sep 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Bringing the path toward an HIV-1 vaccine into focus.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献